Abstract:Abstract Introduction Vagus nerve stimulator (VNS) is used for the treatment of refractory epilepsy. It can alter breathing patterns leading to sleep-disordered breathing (SDB). Screening for SDB is recommended before and after initiation of VNS therapy. We present a case of VNS-induced SDB which responded to continuous positive airway pressure (CPAP) therapy. Report of case(s) A 40-year-old Caucasian female underwent a home sleep apnea test (HSAT) due to symptoms of snoring, difficulty initiating sleep, teeth grinding, vivid dreams, nightmares, excessive daytime fatigue, and sleepiness. She denied parasomnia, symptoms of narcolepsy, and restless leg syndrome. Her habitual sleep duration was 9 hours with a sleep latency of 1 hour. She had 2-3 nighttime awakenings without nocturia. Pertinent medical history included refractory focal epilepsy, traumatic brain injury, insomnia, and attention deficit disorder. Medications were eslicarbazepine 800 mg daily, topiramate 200 mg twice daily, lamotrigine 100 mg daily, trazodone 300 mg nightly, and Adderall 60 mg daily. She had a VNS implanted 5 years ago. VNS settings were frequency of 20 Hz with on and off time of 30 and 60 seconds respectively. Her body mass index was 21 and Epworth Sleepiness Scale score was 15. HSAT showed significant periodic breathing without Cheyne stokes respiration and a 4% apnea-hypopnea index (AHI) of 9.6/hour. Follow-up diagnostic polysomnogram (PSG) revealed periodic breathing with the respiratory events occurring during VNS on time and abnormal sleep architecture including prolonged sleep and rapid eye movement (REM) latency, increased slow wave sleep, and pseudo spindles. The respiratory events were not associated with significant sleep fragmentation or desaturation. The AHI was 6.4/hour. Respiratory events improved with CPAP 7 cmH20 during titration PSG. She will be followed up in the sleep clinic to evaluate the effectiveness of CPAP therapy. Conclusion There is a complex relationship between epilepsy and SDB. Antiepileptics and VNS can cause new onset or worsening SDB. Management options for VNS-induced SDB include PAP therapy, changing VNS settings, or alternate therapies for refractory epilepsy. A multimodal approach requiring input from the patient, a sleep specialist, and an epileptologist is recommended for optimal results. Support (if any)

Vagus nerve stimulation for the treatment of narcolepsy

Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial

Bi-level VNS therapy with different therapy modes at night and daytime improves seizures and quality of life in a patient with drug-resistant epilepsy

1213 Vagal-nerve Stimulation Induced Refractory Central Sleep Apnea

0280 Effect of Daily Transcutaneous Vagal Nerve Stimulation on Objective and Subjective Sleep Features in Healthy Adults

Clinical Investigation of Vagus Nerve Stimulation for Treatment of Drug-Resistant Epilepsy and the Experience of Neuromodulation

Neuroimmunomodulation of vagus nerve stimulation and the therapeutic implications

Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial

Vagus nerve stimulation for the treatment of refractory epilepsy

Recent advances in devices for vagus nerve stimulation

Vagus nerve stimulation (VNS): recent advances and future directions

1225 Vagal Nerve Stimulator-induced Sleep Disordered Breathing

Non-invasive Vagus Nerve Stimulation in Treatment of Disorders of Consciousness – Longitudinal Case Study

Investigation of vagus nerve stimulation for treatment of intractable epilepsy

Chronic Vagus Nerve Stimulation Improves Alertness and Reduces Rapid Eye Movement Sleep in Patients Affected by Refractory Epilepsy

Advances in VNS efficiency and mechanisms of action on cognitive functions

Vagus Nerve Stimulation Modulates Complexity of Heart Rate Variability Differently during Sleep and Wakefulness

The potential of invasive and non-invasive vagus nerve stimulation to improve verbal memory performance in epilepsy patients

Vagus nerve stimulation: a physical therapy with promising potential for central nervous system disorders

Vagus Nerve Stimulation Therapy For The Treatment Of Seizures In Refractory Postencephalitic Epilepsy: A Retrospective Study

Vagus nerve stimulation allows to cease maintenance electroconvulsive therapy in treatment-resistant depression: a retrospective monocentric case series